<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10064103" created="28/04/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10064103</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="peripheral_blood_mononuclear_cell" sem="Cell_natural">Peripheral blood mononuclear cells</term> isolated from <term id="T2" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T3" lex="diabetic_nephropathy" sem="Other">diabetic nephropathy</term> show increased activation of the <term id="T4" lex="oxidative-stress_sensitive_transcription_factor" sem="Protein_family_or_group">oxidative-stress sensitive transcription factor</term> <term id="T5" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>.</sentence>
<event KT="Analysis" id="E1">
<type class="Positive_regulation"/>
<theme idref="T5"/>
<clue><clueLoc>Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy</clueLoc> <clueKT>show</clueKT> <clueType>increased activation</clueType> <linkTheme>of</linkTheme> the oxidative-stress sensitive transcription factor NF-kappaB.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Increased <term id="T6" lex="oxidative_stress" sem="Other">oxidative stress</term> and subsequent activation of the transcription factor <term id="T7" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> has been linked to the development of late <term id="T8" lex="diabetic_complication" sem="Other">diabetic complications</term>.</sentence>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<clue><clueType>Increased</clueType> oxidative stress and subsequent activation of the transcription factor NF-kappaB has been linked to the development of late diabetic complications.</clue>
</event>
<event KT="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="T7"/>
<cause idref="E2"/>
<clue>Increased oxidative stress and <clueType>subsequent activation</clueType> <linkTheme>of</linkTheme> the transcription factor NF-kappaB has been linked to the development of late diabetic complications.</clue>
</event>
<event KT="Other" id="E4">
<type class="Positive_regulation"/>
<theme idref="T8"/>
<clue>Increased oxidative stress and subsequent activation of the transcription factor NF-kappaB has been linked to the <clueType>development</clueType> <linkTheme>of</linkTheme> late diabetic complications.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Correlation"/>
<theme idref="E2"/>
<theme idref="E4"/>
<clue>Increased oxidative stress and subsequent activation of the transcription factor NF-kappaB has been <clueType>linked</clueType> <linkTheme>to</linkTheme> the development of late diabetic complications.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Correlation"/>
<theme idref="E3"/>
<theme idref="E4"/>
<clue>Increased oxidative stress and subsequent activation of the transcription factor NF-kappaB has been <clueType>linked</clueType> <linkTheme>to</linkTheme> the development of late diabetic complications.</clue>
</event>
<sentence id="S3">To determine whether <term id="T9" lex="oxidative_stress" sem="Other">oxidative stress</term> dependent <term id="T10" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation is evident in <term id="T11" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T12" lex="diabetic_nephropathy" sem="Other">diabetic nephropathy</term> we used an <term id="T13" lex="Electrophoretic_Mobility_Shift_Assay" sem="Other">Electrophoretic Mobility Shift Assay</term> based semiquantitative detection system which enabled us to determine <term id="T14" lex="NF-kappaB_activation" sem="Other"><term id="T15" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> in ex vivo <term id="T16" lex="isolated_peripheral_blood_mononuclear_cell" sem="Cell_natural">isolated peripheral blood mononuclear cells</term>.</sentence>
<event KT="Investigation" id="E7" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T10"/>
<cause idref="T9"/>
<clue><clueKT>To determine</clueKT> whether oxidative stress <linkCause>dependent</linkCause> NF-kappaB <clueType>activation</clueType> is evident <clueLoc>in patients with diabetic nephropathy</clueLoc> we used an Electrophoretic Mobility Shift Assay based semiquantitative detection system which enabled us to determine NF-kappaB activation in ex vivo isolated peripheral blood mononuclear cells.</clue>
</event>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<clue>To determine whether oxidative stress dependent NF-kappaB activation is evident in patients with diabetic nephropathy we used an <clueExperiment>Electrophoretic Mobility Shift Assay based semiquantitative detection system</clueExperiment> which enabled us to determine NF-kappaB <clueType>activation</clueType> <clueLoc>in ex vivo isolated peripheral blood mononuclear cells</clueLoc>.</clue>
</event>
<sentence id="S4">We examined 33 <term id="T17" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T18" lex="diabetes_mellitus" sem="Other">diabetes mellitus</term> (Type I and Type II).</sentence>
<sentence id="S5">Patients with <term id="T19" lex="diabetic_nephropathy" sem="Other">diabetic nephropathy</term> showed higher <term id="T20" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding activity in <term id="T21" lex="Electrophoretic_Mobility_Shift_Assay" sem="Other">Electrophoretic Mobility Shift Assays</term> and stronger immunohistological staining for activated <term id="T22" lex="NF-kappaBp65" sem="Protein_molecule">NF-kappaBp65</term> than <term id="T23" lex="patient" sem="Multicellular_organism_natural">patients</term> without <term id="T24" lex="renal_complication" sem="Other">renal complications</term>.</sentence>
<event KT="Other" id="E9">
<type class="Binding"/>
<theme idref="T20"/>
<clue>Patients with diabetic nephropathy showed higher NF-kappaB <clueType>binding</clueType> activity in Electrophoretic Mobility Shift Assays and stronger immunohistological staining for activated NF-kappaBp65 than patients without renal complications.</clue>
</event>
<event KT="Analysis" id="E10">
<type class="Positive_regulation"/>
<theme idref="E9"/>
<clue><clueLoc>Patients with diabetic nephropathy</clueLoc> <clueKT>showed</clueKT> <clueType>higher</clueType> NF-kappaB binding activity <clueExperiment>in Electrophoretic Mobility Shift Assays</clueExperiment> and stronger immunohistological staining for activated NF-kappaBp65 than patients without renal complications.</clue>
</event>
<event KT="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T22"/>
<clue>Patients with diabetic nephropathy showed higher NF-kappaB binding activity in Electrophoretic Mobility Shift Assays and stronger immunohistological staining for <clueType>activated</clueType> NF-kappaBp65 than patients without renal complications.</clue>
</event>
<event KT="Analysis" id="E12">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<clue><clueLoc>Patients with diabetic nephropathy</clueLoc> <clueKT>showed</clueKT> higher NF-kappaB binding activity in Electrophoretic Mobility Shift Assays and <clueType>stronger</clueType> <clueExperiment>immunohistological staining</clueExperiment> for activated NF-kappaBp65 than patients without renal complications.</clue>
</event>
<sentence id="S6"><term id="T25" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding activity correlated with the degree of <term id="T26" lex="albuminuria" sem="Other">albuminuria</term> (r = 0.316) and with <term id="T27" lex="thrombomodulin_plasma_concentration" sem="Other"><term id="T28" lex="thrombomodulin" sem="Protein_molecule">thrombomodulin</term> plasma concentrations</term> (r = 0.33), indicative for <term id="T29" lex="albuminuria" sem="Other">albuminuria</term> associated <term id="A1" sem="Other">endothelial dysfunction</term>.</sentence>
<event KT="Other" id="E13">
<type class="Binding"/>
<theme idref="T25"/>
<clue>NF-kappaB <clueType>binding</clueType> activity correlated with the degree of albuminuria (r = 0.316) and with thrombomodulin plasma concentrations (r = 0.33), indicative for albuminuria associated endothelial dysfunction.</clue>
</event>
<event KT="Analysis" id="E14">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="T26"/>
<clue>NF-kappaB binding activity <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the degree of albuminuria (r = 0.316) and with thrombomodulin plasma concentrations (r = 0.33), indicative for albuminuria associated endothelial dysfunction.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="T28"/>
<clue>NF-kappaB binding activity <clueType><clueKT>correlated</clueKT></clueType> with the degree of albuminuria (r = 0.316) and <linkTheme>with</linkTheme> thrombomodulin plasma concentrations (r = 0.33), indicative for albuminuria associated endothelial dysfunction.</clue>
</event>
<event KT="Other" id="E16">
<type class="Correlation"/>
<theme idref="T29"/>
<theme idref="A1"/>
<clue>NF-kappaB binding activity correlated with the degree of albuminuria (r = 0.316) and with thrombomodulin plasma concentrations (r = 0.33), indicative for albuminuria <clueType>associated</clueType> endothelial dysfunction.</clue>
</event>
<event CL="L2" KT="Analysis" id="E17">
<type class="Correlation"/>
<theme idref="E13"/>
<theme idref="E16"/>
<clue>NF-kappaB binding activity correlated with the degree of albuminuria (r = 0.316) and with thrombomodulin plasma concentrations (r = 0.33), <clueType><clueKT><clueCL>indicative</clueCL></clueKT></clueType> <linkTheme>for</linkTheme> albuminuria associated endothelial dysfunction.</clue>
</event>
<sentence id="S7">In a 3 day intervention study in which 600 mg of the antioxidant <term id="T30" lex="thioctic_acid" sem="Organic_compound_other">thioctic acid</term> (<term id="T31" lex="alpha-lipoic_acid" sem="Organic_compound_other">alpha-lipoic acid</term>) per day were given to nine <term id="A2" sem="Multicellular_organism_natural"><term id="T32" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T33" lex="diabetic_nephropathy" sem="Other">diabetic nephropathy</term></term> <term id="T34" lex="oxidative_stress" sem="Other">oxidative stress</term> in plasma samples was decreased by 48% and <term id="T35" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding activity in ex vivo <term id="T36" lex="isolated_peripheral_blood_mononuclear_cell" sem="Cell_natural">isolated peripheral blood mononuclear cells</term> by 38%.</sentence>
<event KT="Method" id="E19">
<type class="Artificial_process"/>
<theme idref="T31"/>
<theme idref="A2"/>
<clue>In a 3 day intervention study in which 600 mg of the antioxidant thioctic acid (alpha-lipoic acid) per day were <clueType>given</clueType> <linkTheme>to</linkTheme> nine <clueLoc>patients with diabetic nephropathy</clueLoc> oxidative stress in plasma samples was decreased by 48% and NF-kappaB binding activity in ex vivo isolated peripheral blood mononuclear cells by 38%.</clue>
<comment>TPS A2</comment></event>
<event Manner="High" id="E20">
<type class="Negative_regulation"/>
<theme idref="T34"/>
<cause idref="E19"/>
<clue>In a 3 day intervention study in which 600 mg of the antioxidant thioctic acid (alpha-lipoic acid) per day were given to nine patients with diabetic nephropathy oxidative stress <clueLoc>in plasma samples</clueLoc> was <clueType>decreased</clueType> <clueManner>by 48%</clueManner> and NF-kappaB binding activity in ex vivo isolated peripheral blood mononuclear cells by 38%.</clue>
</event>
<event id="E21">
<type class="Binding"/>
<theme idref="T35"/>
<clue>In a 3 day intervention study in which 600 mg of the antioxidant thioctic acid (alpha-lipoic acid) per day were given to nine patients with diabetic nephropathy oxidative stress in plasma samples was decreased by 48% and NF-kappaB <clueType>binding</clueType> activity in ex vivo isolated peripheral blood mononuclear cells by 38%.</clue>
</event>
<event id="E22">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="E19"/>
<clue>In a 3 day intervention study in which 600 mg of the antioxidant thioctic acid (alpha-lipoic acid) per day were given to nine patients with diabetic nephropathy oxidative stress in plasma samples was <clueType>decreased</clueType> by 48% and NF-kappaB binding activity <clueLoc>in ex vivo isolated peripheral blood mononuclear cells</clueLoc> by 38%.</clue>
</event>
<sentence id="S8">In conclusion, activation of the <term id="T37" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> <term id="T38" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in ex vivo <term id="T39" lex="isolated_peripheral_blood_mononuclear_cell" sem="Cell_natural">isolated peripheral blood mononuclear cells</term> of <term id="T40" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T41" lex="diabetes_mellitus" sem="Other">diabetes mellitus</term> correlates with the degree of <term id="T42" lex="diabetic_nephropathy" sem="Other">diabetic nephropathy</term>.</sentence>
<event KT="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="T38"/>
<clue>In conclusion, <clueType>activation</clueType> <linkTheme>of</linkTheme> the transcription factor NF-kappaB <clueLoc>in ex vivo isolated peripheral blood mononuclear cells of patients with diabetes mellitus</clueLoc> correlates with the degree of diabetic nephropathy.</clue>
</event>
<event KT="Analysis" id="E24">
<type class="Correlation"/>
<theme idref="E23"/>
<theme idref="T42"/>
<clue><clueKT>In conclusion</clueKT>, activation of the transcription factor NF-kappaB in ex vivo isolated peripheral blood mononuclear cells of patients with diabetes mellitus <clueType><clueKT>correlates</clueKT></clueType> <linkTheme>with</linkTheme> the degree of diabetic nephropathy.</clue>
</event>
<sentence id="S9"><term id="T43" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation is at least in part dependent on <term id="T44" lex="oxidative_stress" sem="Other">oxidative stress</term> since <term id="T45" lex="thioctic_acid" sem="Organic_compound_other">thioctic acid</term> (<term id="T46" lex="alpha-lipoic_acid" sem="Organic_compound_other">alpha-lipoic acid</term>) reduced <term id="T47" lex="NF-kappaB_binding_activity" sem="Other"><term id="T48" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> binding activity</term>.</sentence>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="T43"/>
<clue>NF-kappaB <clueType>activation</clueType> is at least in part dependent on oxidative stress since thioctic acid (alpha-lipoic acid) reduced NF-kappaB binding activity.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="T44"/>
<clue>NF-kappaB activation is at least in part <clueType>dependent</clueType> <linkCause>on</linkCause> oxidative stress since thioctic acid (alpha-lipoic acid) reduced NF-kappaB binding activity.</clue>
</event>
<event id="E27">
<type class="Binding"/>
<theme idref="T48"/>
<clue>NF-kappaB activation is at least in part dependent on oxidative stress since thioctic acid (alpha-lipoic acid) reduced NF-kappaB <clueType>binding</clueType> activity.</clue>
</event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<cause idref="T46"/>
<clue>NF-kappaB activation is at least in part dependent on oxidative stress since thioctic acid (alpha-lipoic acid) <clueType>reduced</clueType> NF-kappaB binding activity.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
